跳至主要内容
临床试验/NCT06094985
NCT06094985招募中不适用

Prognostic Markers for a Better Follow-up in Head and Neck Cancer.

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年2月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Recurrence

研究概览

简要总结

To identify tumor specific DNA mutations and aberrations and to follow these in blood over time to predict treatment response/survival and secondly to correlate presence of these markers in blood to pathological parameters (LVI, Pn, WPOI and margins), radiological findings and to tumor stage.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient diagnosed with head and neck cancer
  • Treatment includes surgery
  • Consent to participate

排除标准

  • No consent
  • Age below 18 years
  • No surgery
  • No tumor material to sample

结局指标

主要结局

Recurrence

时间窗: 2 years

Recurrent disease within 2 years after surgery. Is presence of these DNA changes in blood correlated to recurrence?

Survival

时间窗: 2 years

Alive/dead. Is presence of these DNA changes in blood correlated to survival?

Treatment response

时间窗: 6 months

Is presence of these DNA changes in blood correlated to treatment response?

次要结局

  • Radiological parameters(9 months)
  • Pathological parameters(6 months)
  • Stage(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anders Näsman

Assoc Prof

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验